FULL MS CLEO REPORT BELOW
TIER 1 — Active Plays (Trade Today)
│ 1 │ DAL │ LONG │ 9.6 A │ Q1 beat + ceasefire fuel │ $72–$73.50 │ $69.50 │ $80 │ 93% │
├─────┼────────┼──────┼───────┼──────────────────────────────────────────────────┼───────────────┼────────┼────────┼──────┤
│ 2 │ HIMS │ LONG │ 9.5 A │ Novo Nordisk GLP-1 partnership + 30% short float │ $19–$19.75 │ $17.50 │ $24 │ 91% │
│ │ │ │ │ = squeeze │ │ │ │ │
├─────┼────────┼──────┼───────┼──────────────────────────────────────────────────┼───────────────┼────────┼────────┼──────┤
│ 3 │ UAL │ LONG │ 9.4 B │ Ceasefire fuel + dark pool confirmed │ $96.50–$98 │ $93 │ $108 │ 92% │
├─────┼────────┼──────┼───────┼──────────────────────────────────────────────────┼───────────────┼────────┼────────┼──────┤
│ 4 │ CCL │ LONG │ 9.2 B │ Cruise lines = ceasefire beneficiary, fuel │ $27.50–$28.50 │ $26 │ $32.50 │ 91% │
│ │ │ │ │ tailwind │ │ │ │ │
TIER 2 — Rumor Intelligence (Watch for Confirmation)
├─────┼────────┼───────────────────────────────────────────────────────────────────────────┼───────┤
│ 6 │ NVDA │ $2.69B dark pool print Mar 30 — institutions loading Q1 earnings │ 9.2 B │
├─────┼────────┼───────────────────────────────────────────────────────────────────────────┼───────┤
│ 7 │ GPCR │ GLP-1 M&A takeover target — Pfizer/Novo Nordisk interest rumored, PT $114 │ 9.0 B │
├─────┼────────┼───────────────────────────────────────────────────────────────────────────┼───────┤
│ 8 │ FRPT │ TD Cowen upgrade to Buy, analyst avg target $83.87 │ 9.0 B │
└─────┴────────┴───────────────────────────────────────────────────────────────────────────┴───────┘
---
SECTOR PLAYS
- XLE SHORT (9.1) — Energy is the weakest sector. Put/call ratio 1.60, structural ceasefire headwind, WTI still not
recovered. Energy worst day in a year yesterday.
- RCL LONG (9.0) — Cruise continuation. Fuel cost tailwind, geopolitical risk off.
---
KEY RUMORS & SENTIMENT RIGHT NOW
- HIMS: Novo Nordisk GLP-1 partnership announced — 30% short float means squeeze mechanics are live. Multi-session hold
candidate.
- GPCR: Being whispered as Pfizer/Novo M&A target. Asymmetric risk — binary outcome.
- Iran ceasefire: Still fragile. IRGC already flagged Israeli strikes in Lebanon as violations. This is the #1 tail risk for
the entire desk.
- Fed: FOMC minutes confirmed rate cuts still on the table for 2026 — oil deflation gives them the green light.